Publications
62
Citations
3,037
Est. group size
~2
Recurring co-author estimate
Active years
22
Publishing since 2005
Veronica Balatti studies small non-coding RNAs, especially microRNAs (miR-155) and tRNA-derived fragments, and how they regulate gene expression in blood cancers such as chronic lymphocytic leukemia (CLL) and lymphoma. Her work explores how these RNA molecules affect immune recognition, tumor growth, and genetic stability, with an eye toward developing new diagnostic tools and targeted or immune-based therapies. Much of the research combines molecular biology experiments with genomic data analysis, including public database development for RNA fragment discovery.
Publication output was higher and more variable earlier in the decade (e.g., 5-7 papers in 2017 and 2019) but has slowed to about 1 per year since 2020, with a low but steady recent output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- <i>miR-155</i> impairs ICOSL and MHC-I expression in DLBCL lymphomas
Proceedings of the National Academy of Sciences · 2025
- <i>MiR-155</i> -targeted IcosL controls tumor rejection
Proceedings of the National Academy of Sciences · 2024
- Small Non-Coding RNAs in Leukemia
Cancers · 2022
- Identification of tRNA‐derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer
Journal of Cellular Physiology · 2020
- Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia
Journal of Clinical Medicine · 2020
- Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorer
Database · 2019
- MicroRNA dysregulation and multi-targeted therapy for cancer treatment
Advances in Biological Regulation · 2019
- HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia
Cancers · 2019
- Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study
Journal of Hematology & Oncology · 2019
- MOESM6 of Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study
Open MIND · 2019
- MOESM7 of Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study
Figshare · 2019
- Novel Mechanisms of Regulation of miRNAs in CLL
Trends in cancer · 2016
- Proceedings of the National Academy of Sciences×8
- Blood×2
- Cancers×2
- The Journal of Experimental Medicine×2
- Cell Death and Differentiation×1
- Yuri Pekarsky
Medicine · The Ohio State University
- Lara Rizzotto
Medicine · The Ohio State University
- Xiaoli Zhang
Medicine · The Ohio State University
- Altan Turkoglu
Medicine · The Ohio State University
- Ethan Hopping
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile